Topical anti-inflammatory agents for seborrheic dermatitis of the face or scalp: summary of a Cochrane Review

JAMA Dermatol. 2015 Feb;151(2):221-2. doi: 10.1001/jamadermatol.2014.3186.

Abstract

Clinical question: Are there differences in effectiveness between topical anti-inflammatory treatments (steroids, calcineurin inhibitors, or lithium salts) and placebo or azoles in the treatment of seborrheic dermatitis of the face and scalp in adults?

Bottom line: The topical anti-inflammatory treatments were more effective in achieving total clearance of symptoms than placebo by 1.4-fold to 8.5-fold, but there are no considerable differences in the anti-inflammatory topical treatments or in comparison with azoles for short-term treatment. There is no evidence of treatment effects in long-term, continuous, or intermittent use of these compounds despite the chronic nature of the disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-Inflammatory Agents / therapeutic use*
  • Dermatitis, Seborrheic / drug therapy*
  • Dermatologic Agents / therapeutic use*
  • Facial Dermatoses / drug therapy*
  • Humans
  • Scalp Dermatoses / drug therapy*

Substances

  • Anti-Inflammatory Agents
  • Dermatologic Agents